Randomized Phase III Study Comparing an Early PET Driven Treatment De Escalation to a Not PET-Monitored Strategy in Patients with Advanced Stages Hodgkin Lymphoma: Interim Analysis of the AHL2011 Lysa Study

被引：0
|
作者：
Casasnovas, Olivier [1 ]
Brice, Pauline [2 ,23 ]
Bouabdallah, Reda [3 ]
Salles, Gilles A. [4 ]
Stamatoullas, Aspasia [5 ]
Dupuis, Jehan [6 ]
Reman, Oumedaly [7 ]
Gastinne, Thomas [8 ]
Joly, Bertrand [9 ]
Bouabdallah, Krimo [10 ]
Nicolas-Virelizier, Emmanuelle [11 ]
Bologna, Serge [12 ]
Morschhauser, Franck [13 ]
Delarue, Richard [14 ]
Farhat, Hassan [15 ]
Quittet, Philippe [16 ]
Berriolo-Riedinger, Alina [17 ]
Tempescul, Adrian [18 ]
Edeline, Veronique [19 ]
Maisonneuve, Herve [20 ]
Eisenmann, Jean Claude [21 ]
Traverse-Glehen, Alexandra [22 ]
Andre, Marc [23 ]
Mounier, Nicolas [24 ]
Meignan, Michel [25 ]
Ferme, Christophe [26 ]
机构：
[1] CHU Dijon, Hop Le Bocage, Dept Hematol, Dijon, France
[2] Hop St Louis, APHP, Hematol, Paris, France
[3] Inst J Paoli I Calmettes, Dept Hematol, Lymphoma Program, F-13009 Marseille, France
[4] Univ Lyon 1, Hosp Civils Lyon, Pierre Benite, France
[5] Ctr Henri Becquerel, Clin Hematol, F-76038 Rouen, France
[6] Grp Hosp Mondor, APHP, Lymphoid Malignancies Unit, Creteil, France
[7] CHU Caen, Hematol, F-14000 Caen, France
[8] CHU Nantes, Dept Hematol, F-44035 Nantes 01, France
[9] Ctr Hosp Sud Francilien, Dept Hematol, Corbeil Essonnes, France
[10] CHU Bordeaux, Bordeaux, France
[11] Ctr L Berard, Dept Hematol, Lyon, France
[12] CHU Nancy, Dept Hematol, Vandoeuvre Les Nancy, France
[13] Univ Lille 2, Ctr Hosp Univ, Hematol, Lille, France
[14] Hop Necker Enfants Malad, AP HP, Hematol, Paris, France
[15] CH Versailles, Dept Hematol, Versailles, France
[16] CHU St Eloi Montpellier, Dept Hematol, Montpellier, France
[17] Ctr GF Leclerc, Dept Nucl Med, Dijon, France
[18] CHU Brest, Hematol Dept, F-29285 Brest, France
[19] Inst Curie, Dept Nucl Med, Paris, France
[20] CH, Dept Hematol & Oncol, La Roche Sur Yon, France
[21] CH Mulhouse, Dept Hematol, Mulhouse, France
[22] Univ Lyon 1, Hosp Civils Lyon, Dept Pathol & Hematol, F-69365 Lyon, France
[23] CHU Dinant Godinne, Dept Hematol, Yvoir, Belgium
[24] Hop LArchet, CHU Nice, Dept Hematol, Nice, France
[25] Grp Hosp Mondor, AP HP, Nucl Med, Creteil, France
[26] Inst Gustave Roussy, Dept Hematol, Villejuif, France
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 46 条
  • [21] Treatment escalation in patients with early stage Hodgkin lymphoma and a positive PET scan after initial chemotherapy is not always required: subsidiary analysis of the UK NCRI RAPID study
    Barrington, S.
    Phillips, E. H.
    Counsell, N.
    Hancock, B.
    Pettengell, R.
    Johnson, P.
    Wimperis, J.
    Culligan, D.
    Popova, B.
    Clifton-Hadley, L.
    McMillan, A.
    Brownell, A.
    Kruger, A.
    Lister, A.
    Hoskin, P.
    O'Doherty, M.
    Illidge, T.
    Radford, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 24 - 24
  • [22] Analysis of the Deauville criteria for the assessment of interim PET in advanced stage Hodgkin lymphoma patients enrolled in the IVS study part I: Diagnostic accuracy and prognostic value
    Kostakoglu, Lale
    Biggi, Alberto
    Barrington, Sally
    Hutchings, Martin
    Meignan, Michel
    Gregianin, Michele
    Chauvie, Stephane
    Gallamini, Andrea
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [23] TREATMENT OF PATIENTS WITH HODGKIN LYMPHOMA IN EARLY FAVOURABLE STAGES: FINAL ANALYSIS OF THE RANDOMIZED GERMAN HODGKIN STUDY GROUP (GHSG) TRIAL HD10
    Eich, H. T.
    Mueller, R. P.
    Pluetschow, A.
    Debus, J.
    Bamberg, M.
    Wilborn, K.
    Eble, M.
    Diehl, V.
    Engert, A.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S158 - S159
  • [24] Analysis of the Deauville criteria for the assessment of interim PET in advanced stage Hodgkin lymphoma patients enrolled in the IVS study part II: Reliability of score and concordance between reviewers
    Biggi, Alberto
    Barrington, Sally
    Hutchings, Martin
    Gregianin, Michele
    Meignan, Michel
    Kostakoglu, Lale
    Chauvie, Stephane
    Gallamini, Andrea
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [25] Response-Adapted Therapy Based on Interim FDG-PET Scans in Advanced Hodgkin Lymphoma: First Analysis of the Safety of Deescalation and Efficacy of Escalation in the International RATHL Study (CRUK/07/033)
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (08) : 6 - 7
  • [26] ROLE OF INTERIM-PET IN POOR PROGNOSIS YOUNG PATIENTS WITH DLBC LYMPHOMA AT DIAGNOSIS: DATA FROM A PROSPECTIVE ANCILLARY STUDY OF A RANDOMIZED PHASE III STUDY FROM THE FONDAZIONE ITALIANA LINFOMI
    Rigacci, L.
    Pregno, P.
    Puccini, B.
    Evangelista, A.
    Chiappella, A.
    Gaidano, G.
    Nassi, L.
    Balzarotti, M.
    Merli, F.
    De Renzo, A.
    Levis, A.
    Spina, M.
    Pavone, V.
    Freilone, R.
    Luminari, S.
    Rossi, G.
    Stelitano, C.
    Carella, A. M.
    D'Arco, A. M.
    Musto, P.
    Kovalchuk, S.
    Benelli, G.
    Bosi, A.
    Vitolo, U.
    HAEMATOLOGICA, 2014, 99 : 412 - 412
  • [27] PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group
    Fuchs, Michael
    Goergen, Helen
    Kobe, Carsten
    Eich, Hans
    Baues, Christian
    Greil, Richard
    Sasse, Stephanie
    Zijlstra, Josee M.
    Lohri, Andreas
    Rosenwald, Andreas
    von Tresckow, Bastian
    Diehl, Volker
    Kuhnert, Georg
    Dietlein, Markus
    Borchmann, Peter
    Engert, Andreas
    BLOOD, 2018, 132
  • [28] Final results of a randomized phase II GELA/LYSA study of rituximab plus ACVBP or CHOP, using a PET-driven consolidation strategy, in patients with high-risk diffuse large B-cell lymphoma (DLBCL).
    Casasnovas, Rene-Olivier
    Ysebaert, Loic
    Thieblemont, Catherine
    Coiffier, Bertrand
    Bologna, Serge
    Lepeu, Gerard
    Delmer, Alain
    Plantier, Isabelle
    Gabarre, Jean
    Andre, Marc
    Senecal, Delphine
    Fruchart, Christophe
    Meignan, Michel
    Berriolo-Riedinger, Alina
    Bardet, Stephane
    Molina, Thierry Jo
    Jais, Jean-Philippe
    Haioun, Corinne
    Tilly, Herve
    Morschhauser, Franck
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] EARLY CHEMOTHERAPY INTENSIFICATION WITH BEACOPP IN HIGH-RISK, INTERIM-PET POSITIVE ADVANCED-STAGE HODGKIN LYMPHOMA, IMPROVES THE OVERALL TREATMENT OUTCOME OF ABVD: A GITIL MULTICENTER CLINICAL STUDY
    Gallamini, A.
    Fiore, F.
    Sorasio, R.
    Rambaldi, A.
    Patti, C.
    Stelitano, C.
    Viviani, S.
    Di Raimondo, F.
    Feldman, T.
    Biggi, A.
    Rossi, A.
    Mistretta, A.
    Bonfante, V.
    Chiarenza, A.
    Cantonetti, M.
    Gavarotti, P.
    Tarella, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 204 - 204
  • [30] PET-Guided Treatment in Patients with Early-Stage Favorable Hodgkin Lymphoma: Follow-up Analysis of the HD16 Trial By the German Hodgkin Study Group
    Fuchs, Michael
    Jacob, Anne Sophie
    Kaul, Helen
    Kobe, Carsten
    Pabst, Thomas
    Greil, Richard
    Eichenauer, Dennis A.
    Topp, Max
    Just, Marianne
    Hertenstein, Bernd
    Schaub, Valdete
    Vogelhuber, Martin
    Zijlstra, Josee M.
    Pluetschow, Annette
    Baues, Christian
    Rosenwald, Andreas
    Dietlein, Markus
    Borchmann, Peter
    Engert, Andreas
    BLOOD, 2021, 138
12345